“…Mutations in SMC1A (Structural Maintenance of Chromosomes 1A) (OMIM 300040), located at Xp11.22 and reported to escape X-inactivation in humans [Brown et al, 1995], account for about 5% of clinically diagnosed CdLS patients who are characterized by phenotypic features similar to, but usually milder than those of the much more numerous (up to 65%) CdLS patients with NIBPL mutations [Borck et al, 2007;Deardorff et al, 2007;Limongelli et al, 2010;Pié et al, 2010;Rohatgi et al, 2010;Hoppman-Chaney et al, 2011]. To date, 44 CdLS individuals harboring 29 unique SMC1A mutations (23 missense and six in-frame deletions) have been described: 33 sporadic and 11 belonging to four families, with a 2:1 female:male ratio (29 females and 14 males plus one patient whose sex was not specified) [Borck et al, 2007;Deardorff et al, 2007;Liu et al, 2009;Limongelli et al, 2010;Mannini et al, 2010;Pié et al, 2010;Hoppman-Chaney et al, 2011, http://grenada.lumc.nl/LOVD2/CDLS/home.php?select_db¼SMC1A].…”